Evaluation of the Combination 5-Fluorouracil, Dacarbazine, and Epirubicin in Patients With Advanced Well-Differentiated Neuroendocrine Tumors (Q42870246)
Jump to navigation
Jump to search
scientific article published on October 1, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the Combination 5-Fluorouracil, Dacarbazine, and Epirubicin in Patients With Advanced Well-Differentiated Neuroendocrine Tumors |
scientific article published on October 1, 2010 |
Statements
1 reference
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors (English)
1 reference
Evaluation of the Combination 5-Fluorouracil, Dacarbazine, and Epirubicin in Patients With Advanced Well-Differentiated Neuroendocrine Tumors (English)
1 reference
Domitille Bruneton
1 reference
Valérie Hervieu
1 reference
Frank Pilleul
1 reference
Jean Yves Scoazec
1 reference
Jean Alain Chayvialle
1 reference
1 October 2010
1 reference
1 reference
1 reference
9
1 reference
4
1 reference
248-254
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference